One month after posting year-end sales growth in its 2003 financial report, shareholders of contrast developer Amersham voted to approve the company’s pending acquisition by GE Healthcare of Waukesha, WI.
The Buckinghamshire, U.K.-based firm said it expects the deal to be completed on April 8. On the basis of that closing date, a 10-day trading period on which the exchange ratio in the all-stock deal is calculated will begin on March 23 and end on April 5, Amersham said.
GE will form a new GE Healthcare Technologies Life Science business unit to include the Amersham operations. The division will be led by William Castell, currently Amersham’s chief executive, and will be based in the U.K. Castell will lead the integration effort of the two businesses.
By AuntMinnie.com staff writers
March 19, 2004
Related Reading
Amersham sales grow in 2003, February 19, 2004
GE/Amersham deal clears hurdle, January 22, 2004
Amersham shows growth in Q3, October 30, 2003
Amersham re-ups with Novation, October 24, 2003
GE makes $9.8 billion bid for Amersham, October 10, 2003
Copyright © 2004 AuntMinnie.com
